nandrolone has been researched along with Weight Loss in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beck, K; Bhasin, S; Geurts, P; Harms, MK; Mac, P; Padero, M; Sattler, F; Schroeder, ET; Singh, AB; Storer, TW; Willemsen, A; Woodhouse, LJ; Yarasheski, KE | 1 |
Cordova, F; King, DA; Scharf, SM | 1 |
Gorbacheva, ES; Gruzdev, BM; Ivannikov, EV | 1 |
Batterham, MJ; Garsia, R | 1 |
1 review(s) available for nandrolone and Weight Loss
Article | Year |
---|---|
Nutritional aspects of chronic obstructive pulmonary disease.
Topics: Body Composition; Body Mass Index; Clinical Trials as Topic; Humans; Megestrol Acetate; Nandrolone; Nutrition Disorders; Nutritional Support; Prognosis; Pulmonary Disease, Chronic Obstructive; Testosterone; Weight Loss | 2008 |
2 trial(s) available for nandrolone and Weight Loss
Article | Year |
---|---|
A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
Topics: Adipose Tissue; Adult; Anabolic Agents; Appetite; Blood Glucose; Body Composition; Gonadal Steroid Hormones; HIV Wasting Syndrome; Human Growth Hormone; Humans; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; Nandrolone; Nandrolone Decanoate; Physical Endurance; Placebos; Quality of Life; Severity of Illness Index; Sexuality; Weight Loss | 2005 |
A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss.
Topics: Adult; Anabolic Agents; Appetite; Counseling; Eating; HIV Wasting Syndrome; Humans; Male; Megestrol Acetate; Middle Aged; Nandrolone; Nandrolone Decanoate; Prospective Studies; Weight Loss | 2001 |
1 other study(ies) available for nandrolone and Weight Loss
Article | Year |
---|---|
[Anabolic therapy in patients with HIV infections].
Topics: Adult; Anabolic Agents; Appetite; Body Mass Index; Diarrhea; Female; HIV; HIV Infections; Humans; Injections, Intramuscular; Male; Nandrolone; Quality of Life; Treatment Outcome; Weight Loss | 1999 |